PRSS3 and cancer: Using an LAC-derived cell line with high endogenous expression of PRSS3, we show that silencing of PRSS3 gene expression, or inhibition of mesotrypsin activity, suppresses cancer cell growth and invasion, implicating mesotrypsin as a driver of malignancy in LAC.